Dr. Hass was awarded a three year research grant in 2011 from the National Institutes of Health to develop a series of chemical compounds that could prove instrumental in limiting the harmful effects of the sun’s ultraviolet (UV) rays.
Research Description
Our lab works on the synthesis of novel co-drugs aimed at treating skin diseases, the development of stable topical formulations for these compounds, assessment of penetration and accumulation of topical experimental drugs in skin (using an ex vivo skin model) and evaluating efficacy using in vitro assays.
Positions
Professor (Pharmaceutical Sciences)
Albany College of Pharmacy and Health Sciences
1991
Education
PhD (Chemistry)
Rensselaer Polytechnic Institute
1988
BS (Chemistry)
University of Vermont
1983
Professional Affiliations
American Association of Pharmaceutical Sciences
American Association of Pharmaceutical Sciences
American Chemical Society
American Chemical Society
Publications
Combination Effects of Aminolevulinic Acid and Mycophenolic Acid on Hacat Cell Proliferation and Inhibition of Inosine Monophosphate Dehydrogenase
Molecules
30
1359
(2025)
The effect of α-and δ-tocopherol-lipoic acid ester co-drugs on the response of the rabbit bladder to in vitro ischemia/reperfusion
Türk Üroloji Dergisi/Turkish Journal of Urology
45
289-295
(2019)
Stability, Cutaneous Delivery, and Antioxidant Potential of a Lipoic Acid and α-Tocopherol Codrug Incorporated in Microemulsions
Journal of Pharmaceutical Sciences
103
2530-2538
(2014)